Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GAR1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | RBMX | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | SUV39H2 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | CEP162 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | SCAF8 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | TRIOBP | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | TBC1D24 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | NELL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | SH2D4A | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | H2AFY2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |